Loading chart...





The current price of BLAC is 0 USD — it has increased 0
Bellevue Life Sciences Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The Company has not selected any business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company may pursue an acquisition opportunity in any business industry or sector. The Company intends to acquire and manage a business in the healthcare industry, more specifically in the biotechnology sector. The Company neither engaged in any operations nor generated any revenues.
Wall Street analysts forecast BLAC stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for BLAC is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Bellevue Life Sciences Acquisition Corp revenue for the last quarter amounts to -454.13K USD, increased 10.65
Bellevue Life Sciences Acquisition Corp. EPS for the last quarter amounts to -226880.00 USD, increased 58.41
Bellevue Life Sciences Acquisition Corp (BLAC) has 0 emplpoyees as of April 04 2026.
Today BLAC has the market capitalization of 43.48M USD.